Edition:
India

Galapagos NV (GLPG.AS)

GLPG.AS on Amsterdam Stock Exchange

169.65EUR
2:47pm IST
Change (% chg)

€6.95 (+4.27%)
Prev Close
€162.70
Open
€162.80
Day's High
€170.15
Day's Low
€161.20
Volume
412,421
Avg. Vol
454,472
52-wk High
€170.15
52-wk Low
€74.48

About

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and... (more)

Overall

Beta: 1.51
Market Cap(Mil.): €8,919.72
Shares Outstanding(Mil.): 54.82
Dividend: --
Yield (%): --

Financials

S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high

NEW YORK The benchmark S&P 500 index ended little changed on Monday after oscillating between positive and negative territory throughout the session after Citigroup Inc kicked off the earnings season with a mixed quarterly report. | Video

16 Jul 2019

S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high

NEW YORK The benchmark S&P 500 index ended little changed on Monday after oscillating between positive and negative territory throughout the session after Citigroup Inc kicked off the earnings season with a mixed quarterly report. | Video

16 Jul 2019

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

16 Jul 2019

US STOCKS-S&P ends near flat as Citigroup results sink banks; Nasdaq hits new high

* Boeing drops on report 737 MAX groundings could extend to 2020

16 Jul 2019

Gilead invests $5 billion to deepen ties with biotech Galapagos

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos's shares more than 18% to an all-time high on Monday.

16 Jul 2019

UPDATE 4-Gilead invests $5 bln to deepen ties with biotech Galapagos

* Gilead makes $3.95 bln upfront payment, $1.1 equity investment

16 Jul 2019

US STOCKS-S&P trades near flat as Citigroup results weigh on bank stocks

* Dow flat, S&P flat, Nasdaq up 0.18% (Updates to late afternoon New York trade, changes byline, adds NEW YORK to dateline)

16 Jul 2019

US STOCKS-Wall Street slightly lower as Citi results weigh on bank stocks

* Indexes down: Dow 0.12%, S&P 0.15%, Nasdaq 0.07% (Updates to early afternoon)

15 Jul 2019

Deals of the day-Mergers and acquisitions

July 15 The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday:

15 Jul 2019

Factbox: The Galapagos drugs pipeline that has drawn in Gilead

U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV .

15 Jul 2019

Earnings vs. Estimates